- Krystal Biotech (KRYS) is scheduled to announce Q3 earnings results on Monday, November 2nd, before market open.
- The consensus EPS Estimate is $1.92 (-27.8% Y/Y) and the consensus Revenue Estimate is $126.54M (+29.4% Y/Y).
- Over the last 2 years, KRYS
